Unclaimed Scholar Profile
Are you Michele D. Tameris? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at University of Cape TownASIDASID-8017-2270-0272 orcid.org/0000-0002-7983-7203
Michele D. Tameris
University of Cape Town•South Africa
Faculty researcher at University of Cape Town (ZA), specializing in Physical Sciences & Engineering. [Discipline: Physical Sciences & Engineering] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#Tuberculosis Research and Epidemiology#Infectious Diseases and Tuberculosis#Immune responses and vaccinations#Diagnosis and treatment of tuberculosis
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 7,403 | 3,553 |
| h-index | 40 | 30 |
| i10-index | 80 | 56 |
Annual Citation Growth
Verified Citations / Year0
2020355
2021+40%497
2022+29%640
2023+33%853
2024-8%782
2025-46%426
2026Scholarship Distribution & Proportions122 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (6,070) • 18% Global Research Impact (1,333)
122 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (122)
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
Published in The Lancet•2013
DOI: 10.1016/s0140-6736(13)60177-4 Verified Peer-Reviewed
Final Analysis of a Trial of M72/AS01 E Vaccine to Prevent Tuberculosis
Published in New England Journal of Medicine•2019
DOI: 10.1056/nejmoa1909953 Verified Peer-Reviewed
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
Published in New England Journal of Medicine•2021
DOI: 10.1056/nejmoa2103055 Verified Peer-Reviewed
Phase 2b Controlled Trial of M72/AS01 E Vaccine to Prevent Tuberculosis
Published in New England Journal of Medicine•2018
DOI: 10.1056/nejmoa1803484 Verified Peer-Reviewed
T-cell activation is an immune correlate of risk in BCG vaccinated infants
Published in Nature Communications•2016
DOI: 10.1038/ncomms11290 Verified Peer-Reviewed
Showing 1 – 5 of 122 publications
1 / 25